VKTX
Viking Therapeut (VKTX)
NASDAQ
$34.89+$2.52 (+7.78%)
Price as of Jun 23, 2026 6:58 PM EDT
  • $3.8B
    Market Cap
  • 30.21%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
55,000
-50.89%
112,000
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
55,000
-50.89%
112,000
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-345.0M
+239.38%
-101.6M
+59.30%
-63.8M
+17.65%
-54.2M
+20.57%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
393.3M
+160.63%
150.9M
+49.68%
100.8M
+43.31%
70.4M
+26.35%
Operating Profit
-393.3M
+160.63%
-150.9M
+49.68%
-100.8M
+43.31%
-70.4M
+26.35%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
33.7M
-17.71%
41.0M
+174.30%
14.9M
+903.49%
1.5M
+115.03%
Income before Taxes
-393.3M
+160.63%
-150.9M
+49.68%
-100.8M
+43.31%
-70.4M
+26.35%
Income Taxes
1,000
0.00%
1,000
0.00%
1,000
0.00%
1,000
-50.00%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-359.6M
+227.05%
-110.0M
+28.02%
-85.9M
+24.73%
-68.9M
+25.24%
Net Income from Continuing Operations Applicable to Common
-359.6M
+227.05%
-110.0M
+28.02%
-85.9M
+24.73%
-68.9M
+25.24%
Basic EPS and Net Income
-3.19
+215.84%
-1.01
+10.99%
-0.91
+1.11%
-0.90
+26.76%
Diluted EPS and Net Income
-3.19
+215.84%
-1.01
+10.99%
-0.91
+1.11%
-0.90
+26.76%
Basic Weighted Average Shares
112.7M
+3.33%
109.0M
+15.57%
94.3M
+22.79%
76.8M
-0.47%
Diluted Weighted Average Shares
112.7M
+3.33%
109.0M
+15.57%
94.3M
+22.79%
76.8M
-0.47%
Balance Sheet
Cash and Cash Equivalents
165.8M
+521.57%
26.7M
-51.95%
55.5M
+51.55%
36.6M
+38.91%
Short-Term Investments
539.9M
-38.36%
875.9M
+185.73%
306.6M
+157.93%
118.9M
-32.37%
Cash and Cash Equivalents and Short-Term Investments
705.7M
-21.81%
902.6M
+149.29%
362.1M
+132.87%
155.5M
-23.07%
Total Current Assets
715.6M
-21.12%
907.2M
+147.05%
367.2M
+119.84%
167.0M
-20.66%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
715.7M
-21.20%
908.3M
+146.50%
368.5M
+118.65%
168.5M
-20.00%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
76.7M
+179.67%
27.4M
+43.26%
19.1M
-12.81%
21.9M
+150.02%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
0
-100.00%
630,000
-32.69%
936,000
-25.71%
1.3M
+4,244.83%
Total Liabilities
76.7M
+173.39%
28.0M
+39.72%
20.1M
-13.51%
23.2M
+164.38%
Retained Earnings
-847.5M
+73.71%
-487.9M
+29.10%
-377.9M
+29.41%
-292.0M
+30.86%
Total Stockholders Equity
639.1M
-27.40%
880.3M
+152.65%
348.4M
+139.76%
145.3M
-28.02%
Total Shares Outstanding
114.8M
+2.89%
111.6M
+11.45%
100.1M
+27.93%
78.3M
+0.01%
Cash Flow
Cash from Operating Activities
-278.7M
+217.45%
-87.8M
+19.64%
-73.4M
+51.61%
-48.4M
+1.70%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
341.4M
+161.69%
-553.4M
+208.99%
-179.1M
-427.08%
54.8M
+44.24%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
76.4M
-87.52%
612.5M
+125.69%
271.4M
+6,418.76%
4.2M
-39.49%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-715,167.27%
+430.73%
-134,750.89%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-44.29%
+157.13%
-17.22%
-46.16%
-31.99%
-11.93%
-36.32%
+54.29%
Return on Equity
-47.34%
+164.49%
-17.90%
-48.56%
-34.79%
-12.29%
-39.67%
+60.95%
Revenue Growth
-50.89%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
9.33
-71.80%
33.09
+72.44%
19.19
+152.15%
7.61
-68.27%
Cash Ratio
2.16
+122.25%
0.97
-66.46%
2.90
+73.82%
1.67
-44.44%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow